The effects of arachidonic acid and thrombin on calcium movements have been studied in fura-2-loaded platelets by a procedure which allows simultaneous monitoring of the uptake of manganese, a calcium surrogate for Ca2+ channels, and the release of Ca2+ from intracellular stores. Arachidonic acid induced both Ca2+ (Mn2+) entry through the plasma membrane and Ca2+ release from the intracellular stores. The release of Ca2+ was prevented by cyclo-oxygenase inhibitors and mimicked by the prostaglandin H2/thromboxane A2 receptor agonist U46619. Ca2+ (Mn2+) entry required higher concentrations of arachidonic acid and was not prevented by either cyclo-oxygenase or lipoxygenase inhibitors. Several polyunsaturated fatty acids reproduced the effect of arachidonic acid on Ca2+ (Mn2+) entry, but higher concentrations were required. The effects of maximal concentrations of arachidonic acid and thrombin on the uptake of Mn2+ were not additive. Both agonists induced the entry of Ca2+, Mn2+, Co2+ and Ba2+, but not Ni2+, which, in addition, blocked the entry of the other divalent cations. However, arachidonic acid, but not thrombin, increased a Ni2+-sensitive permeability to Mg2 . The effect of thrombin but not that of arachidonic acid was prevented either by pretreatment with phorbol ester or by an increase in cyclic-AMP levels. Arachidonic acid also accelerated the uptake of Mn2+ by human neutrophils, rat thymocytes and Ehrlich ascites-tumour cells.
INTRODUCTION
Stimulation of platelets by a variety of agonists produces a rise in the cytoplasmic free Ca2+ concentration ([Ca2+] ) due to both release of Ca2+ from the intracellular stores and entry through the plasma membrane [1] [2] [3] . The nature and the activation mechanism of the entry pathway are little known [4] . Ca2+ channels have been recently incorporated into lipid planar bilayers using plasma membranes prepared from thrombinstimulated platelets; these channels were also permeable to Mn2+ and were blocked by Ni2+ [5] . This is consistent with previous reports showing that thrombin induced a Ni2+-inhibitable entry of Ca21 or Mn2+ into quin2-loaded cells [6] . These observations have recently been extended to other agonists using fura-2-loaded platelets [7] [8] [9] [10] . The spectral properties of fura-2 allow, in addition, the separate quantification of the entry of Mn2+ through the plasma membrane and the release of Ca2+ from intracellular stores, both of which take place simultaneously with most agonists [9, 10] .
Externally added arachidonic acid is able to activate human platelets. A biphasic effect is observed, with low (< 20 /LM) concentrations inducing aggregation and secretion which are sensitive to aspirin, and larger concentrations producing aspirininsensitive activation [11] [12] [13] [14] . We have reported previously that high concentrations of arachidonic acid accelerate the entry of Mn2+ into human platelets and that this effect is blocked by Ni2+ [10] . It has also been shown that arachidonic acid induces 45Ca release from plasma membrane vesicles [15] and from microsomes [16] prepared from human platelets.
Thrombin induces release of arachidonic acid from membrane phospholipids by activation of phospholipase A2 [17] . It has been reported recently that Ca2+ mobilization induced by thrombin is decreased by treatment of platelets with the phospholipase A2 inhibitor ONO-RS-082 [15] . On the other hand, microinjection of phospholipase A2 increased Ca2+ influx in cultured endothelial cells [18] . These results suggest the interesting possibility that arachidonic acid might mediate the effects of thrombin on Ca2+ mobilization. In this paper, the effects of arachidonic acid on Ca2+ mobilization in human platelets are analysed in detail and compared with the effects of thrombin.
EXPERIMENTAL
Platelets were prepared from freshly drawn human blood as described elsewhere [19, 20] and suspended at 109 cells/ml in an incubation medium containing (in mM): NaCl, 140; KCI, 5; MgSO4, 1; glucose, 10; and sodium-Hepes, 10 (pH 7.4). Apyrase (20 #sg/ml) was added to prevent activation by traces of ADP.
The cells were loaded with fura-2 by incubation with 2-5 4uM-fura-2/AM for 45 min at room temperature. The platelet suspension was then diluted three times with incubation medium containing 2% acid citrate-dextrose solution (ACD), and the cells were sedimented by centrifugation (350 g, 20 min ) and resuspended at 2 x 108/ml in fresh incubation medium. Fluorescence was measured at 37°C and under magnetic stirring in 0.5 ml portions of cell suspension using a fluorescence spectrophotometer constructed by Cairn Research Ltd. (Newnham, Sittingbourne, Kent, U.K.). The system allows quick Hz) alternation of up to six excitation wavelengths and separate reading of the corresponding fluorescence emissions. In the present experiments fluorescence was excited at 340, 360, 380, 450 and 492 nm and read at 530 nm. Readings were integrated at 1 s intervals.
Activation of plasma membrane Ca2+ channels and release of Ca2+ from intracellular stores were monitored simultaneously and independently in fura-2-loaded platelets by using the procedure described elsewhere [9, 10] . Briefly, Mn2+ was added to the extracellular medium, which was nominally Ca2+-free, to act as a [21] were (in nM): Mn, 1.6; Co, 3.2; Ni, 10; Ba, 1000.
Intracellular pH (pH1) was measured in platelets previously loaded with bis-carboxyethylcarboxyfluorescein (BCECF [22] ) by incubation with 0.5-2 UM of the acetoxymethyl ester under conditions similar to those described above for fura-2. In some experiments the cells were loaded simultaneously with both fura-2 and BCECF. Intracellular pH was estimated from the ratio of the fluorescences excited at 492 and 450 nm and measured at 530 nm in the Cairn spectrofluorimeter described above. Calibrations were performed with nigericin in high-K+ medium [23] .
Mg2+ fluxes were measured in platelets first loaded with the Mg2+-sensitive dye mag-indo-1 [24] by incubation with 8,M of the acetoxymethyl ester under conditions similar to those described above for fura-2. Loaded cells were then incubated at M. T. Alonso, A. Sanchez and J. Garcia-Sancho 37°C under magnetic stirring in the sample compartment of a Hitachi 650-10 S spectrofluorimeter and fluorescence was measured at 340 nm excitation 410 nm emission.
Arachidonic acid metabolism was measured in cells first labelled by incubation with [3H]arachidonic acid (30 uCi/ml; specific radioactivity 240 Ci/mmol) in plasma containing 50 nmprostaglandin Ei and 20 ,tg of apyrase/ml for 90 min at 37 'C.
The cells were then washed twice with plasma and once more with incubation medium containing 2 % ACD, apyrase (20 ,ug/ml) and albumin (1 mg/ml). Finally the cells were resuspended at 1 x 108 cells/ml in regular incubation medium. After different periods of incubation at 37 'C with or without agonists or inhibitors the incubation was terminated by mixing 0.5 ml portions of cell suspension with 0.5 ml of ice-cold 0.5 Mformic acid. The samples were extracted with 2 vol. of ethyl acetate, and arachidonic acid metabolites were separated by t.l.c. [25] .
Preparation and handling of human neutrophils [26] , Ehrlich ascites-tumour cells [27] and rat thymocytes [28] were as described elsewhere.
[ [9, 10] . With our particular set of filters the value of k was 0.62.
[Ca2+]i was calculated from the ratio F340/F380 [21] . In release of Ca2+ from the intracellular stores (Fig. lb) . Arachidonic acid produced both a concentration-dependent increase of Mn2+ uptake and a release of Ca2+ from the intracellular stores, but the latter effect was decreased by increasing the concentration'of arachidonic acid above 10 4UM (Fig. lb) . Fig. 1(c) shows a dose-response curve summarizing the results of several similar experiments. A bell-shaped curve centred near 10lM-arachidonic acid was observed for Ca2+ release. This is consistent with previous reports [13, 14] . In contrast, the effect on Mn2+ uptake appeared only above 10 ,uM and was maximal (estimated rate near 70 mmol/h per litre of cells) at 60 #uM.
Since the concentrations of arachidonic acid needed to increase the uptake of Mn2+ were rather high, it was critical to establish that these effects were not due to non-selective permeabilization of the plasma membrane. None of the concentrations of arachidonic acid used resulted in release of either lactate dehydrogenase or fura-2 into the incubation medium (results not shown). It could be argued, however, that the membrane permeability to smaller molecules could be increased. Fig. 2 shows that the quenching of fura-2 fluorescence induced by addition of arachidonic acid in Mn2+-containing medium was prevented by the simultaneous presence of Ni2+. It can be seen that the subsequent addition of ionomycin, which does not transport Ni2+, induced quenching of fura-2 by Mn2+ entering. The third trace in Fig. 2 shows that arachidonic acid did not induce uptake of Ni2+, since no quenching of fura-2 fluorescence was produced. The subsequent addition ofalamethicin, a divalent cation ionophore with little specificity [29] , resulted in entry of Ni2+. These results show that: (i) arachidonic acid treatment does not release fura-2 into the medium; (ii) it does not increase the plasma membrane permeability to Ni2+; and (iii) Ni2+ prevents the increase in the uptake of Mn2+ induced by arachidonic acid. Ni2+ did not modify the release of Ca2+ from the intracellular stores induced by arachidonic acid (results not shown). Fig. 3 shows the effects of the sequential addition of Mn2+, EGTA and TPEN on the fluorescence of fura-2-loaded platelets. After addition of Mn2+ there was a quick decrease in fluorescence which was due to quenching of the extracellular dye leaked out from the cells. This was followed by a slower decrease due to entry ofMn2 . On addition of EGTA, which chelates extracellular divalent cations, there was an abrupt increase in fluorescence. This corresponds to the increase in the fluorescence of extracellular fura-2 on going from the quenched state (fura-2-Mn2+ complex) to the minimal fluorescence state (unbound fura-2). The fluorescence then remains stable, indicating that Mn2+ is no longer entering the cells. Addition of TPEN, a lipophilic membrane-permeable chelator which binds heavy divalent cations but not Ca2+ or Mg2+ [30] , had little or no effect. In the right-hand trace (Fig. 3 ), the addition of arachidonic acid after Mn2+ greatly accelerated the quenching of fura-2 fluorescence, reflecting Mn2+ uptake. The subsequent addition of EGTA produced an abrupt rise in fluorescence followed by a slower rise. This suggests a slow exit of Mn2+ on chelation of the extracellular cation. The addition of TPEN then produced a fast increase in fluorescence, reflecting the binding of intracellular Mn2+ by the entering lipophilic chelator. These results prove that the cell membrane is still acting as a barrier for fura-2, EGTA and Mn2+ after treatment with arachidonic acid.
Additional support for the selectivity of the action of arachidonic acid was obtained by studying its effects on H+ movements. Fig. 4 shows the results of a typical experiment with platelets loaded with BCECF. Mn2+ was added to the medium in order to simulate exactly the same conditions as in the Mn2+-influx experiments. In the first trace the addition of the weak base Vol. 272 trimethylamine (TMA) produced an increase in fluorescence. This reflects the faster uptake of the uncharged species relative to the trimethylammonium ion, resulting in cytoplasmic alkalinization [31] . The detergent Triton X-100 was added about 30 s later, resulting in a large increase in fluorescence. This arises mostly from the shift of the BCECF spectrum on release from the cells [32] . As shown in the second trace, the addition of arachidonic acid produced a quick decrease of fluorescence (acidification) followed by a slower increase which slightly surpassed the level before arachidonic acid addition. A similar biphasic pH, shift has been reported before in response to thrombin. The fast acidification arises from an increased production of HI and the slower alkalinization is the.result of the stimulation of Na+/H+ exchange [20, 33, 34] . It seems from these results that arachidonic acid reproduced the effects of thrombin on HI movements. Although this point was not addressed here, the stimulation of Na+/H+ exchange should be expected, since these concentrations of arachidonic acid have been reported to stimulate directly protein kinase C (PKC) [13, 35] , which could, in turn, activate Na+/H+ exchange [36] . What matters here is that addition of TMA after arachidonic acid produced the same cytoplasmic akalinization as seen in control cells which were not treated with arachidonic acid. This result proves that: (i) the physiological difference in permeability between the charged and the uncharged species of TMA was preserved; and (ii) the plasma membrane permeability to HI was not changed by arachidonic acid. The final addition of Triton X-100 produced the same changes in fluorescence as in the control cells, again supporting the view that the cells were not lysed before the addition of the detergent.
Arachidonic acid is metabolized in human platelets through two main pathways. The cyclo-oxygenase pathway results in thromboxanes and prostaglandins and it can be inhibited by aspirin [17] . The lipoxygenase pathway results in hydroperoxy and hydroxy derivatives and can be blocked by nordihydroguaiaretic acid (NDGA) [17, 37, 38] . In order to assess whether the effects of arachidonic acid were mediated by one of these metabolites, the effects of inhibitors were tested. Fig. 5 shows that aspirin treatment blocked the release of Ca2l from the intracellular stores effected by arachidonic acid. On the other hand, the prostaglandin H2/thromboxane A2 receptor agonist U46619 [3] reproduced the action of arachidonic acid on Ca2+ release, the effect being, in this case, insensitive to aspirin (Fig. 5) .
These results indicate that the release of Ca2+ from the intracellular stores induced by arachidonic acid is mediated by cyclo-oxygenase metabolites. This is consistent with previous evidence [11] [12] [13] .
On the contrary, the effects of arachidonic acid on the uptake of Mn2+ were not mimicked by U46619 (Fig. 6 ) or inhibited by aspirin (Fig. 7a) . Fig. 7(b) shows that treatment with NDGA also failed to modify the effects of arachidonic acid on the uptake of Mn2+. The dual cyclo-oxygenase and lipoxygenase inhibitor BW755C [39] also did not prevent the acceleration of Mn2+ uptake induced by arachidonic acid (Fig. 7c) . The effects of the inhibitors on thrombin-induced arachidonic acid metabolism were tested in parallel experiments with cells labelled with
[3H]arachidonic acid. Aspirin, as expected, completely prevented thromboxane A2 formation and increased the levels of arachidonic acid, hydroxyeicosatetraenoic acid (HETE) and hydroxyheptadecatrienoic acid (HHT). BW755C effectively prevented the formation of all the metabolites, i.e. thromboxane A2, HETE and HHT, and increased the levels of free arachidonic acid. This confirms inhibition of both lipoxygenase and cyclooxygenase. NDGA had exactly the same effects as BW755C, suggesting that, in spite of previous claims for selective lipoxygenase inhibition [37, 38] , NDGA antagonizes both cyclo- Other fatty acids were tested in order to assess the specificity of the arachidonic acid effect. Linoleic acid reproduced the effects of arachidonic acid on the uptake of Mn2+, although higher concentrations were required. This fatty acid, however, was unable to induce Ca21 mobilization from the intracellular stores (Fig. 8) . Table I other fatty acids tested were at most one-twentieth as effective as arachidonic acid. At 200 gSM, the following general trends were observed. (i) None of the saturated fatty acids was active; the effect required the presence of several double bonds in the cis configuration and increased with the degree of unsaturation. (ii) The position of the double bonds relative to the terminal methyl group was also important, the fatty acids of the -6 series being more active than those of the -3 series. (iii) A free carboxyl group was required.
Some of the fatty acids tested showed a lag of 2-5 s before the increase in Mn2+ uptake occurred. This is shown for linoleic acid in Fig. 8, and acid derivatives a [Ca2+]1 peak was observed, suggesting contamination with or fast intracellular production of some arachidonic acid.
In order to investigate whether the plasma membrane pathway opened by arachidonic acid was the same as that activated by thrombin, the additivity of the effects of the two agonists was tested. The rationale was that, if different pathways were opened by each agonist, the rate of Mn2+ uptake obtained after their joint addition should be the sum of the rates obtained after separate additions. The feasibility of this approach was tested by comparing the rates of Mn2+ uptake obtained after the joint and the separate additions of 60,#M-arachidonic acid and 0.4,UMionomycin. The rates obtained were (decrease of fluorescence/s; means + S.E.M.): arachidonic cid, 9.1 ± 1.6; ionomycin, 18.4 ± 1.7; arachidonic acid + ionomycin, 28.7 + 2.9. Fig. 9 compares the effects of thrombin, arachidonic acid and the joint addition of both agonists on the uptake of Mn2+. No additivity was observed when both agonists were used at concentrations giving maximal individual effects (Fig. 9a) , suggesting that they open the same Mn2+ pathway. However, this interpretation was questioned by the results shown in Fig. 9(b) . A low concentration of arachidonic acid, having by itself no effect on Mn2+ uptake was, however, able to prevent the effect of thrombin. The outcome was even more complicated when submaximal concentrations of arachidonic acid were used. In this case the effect of the joint addition of both agonists was smaller than the effect of either of them separately (results not shown).
In order to compare the selectivity of the plasma membrane pathways opened by arachidonic acid and thrombin, the effects of these agonists on the uptake of other divalent cations were studied. Fig. 10 compares the effects on the uptake of Mn2+, Co2+ and Ba2+. Mn2+ and Co2+ quench the fluorescence of fura-2, whereas Ba2+ increases the fluorescence excited at 360 nm (see the Experimental section). Both agonists increased the uptake of all three divalent cations. In all cases the effects were prevented by Ni2+ (results not shown). The uptake of Mn2+ was faster than that of Co2+. The rate for Ba2+ could not be compared directly, but the relative rates (Mn2 /Ba2+) seemed to be similar for arachidonic acid and for thrombin. Thrombin produced a decrease in fluorescence with zero Mg2+ and did not modify it at 5 mM-Mg2+. At 1 mM-Mg2+ thrombin produced either no effect or a small decrease in fluorescence in different experiments (results not shown). The effects of thrombin were not affected by Ni2+. These results suggest that the decrease in fluorescence obtained with zero Mg2+ was artifactual and that thrombin does not increase plasma membrane permeability to Mg2+
In order to analyse further the similarities and the differences between the effects of arachidonic acid and thrombin, several conditions which are known to inhibit platelet function were tested. Pretreatment of platelets with phorbol esters is known to prevent the increase in [Ca2+]1 induced by thrombin [40] [41] [42] [43] . Fig. 12 shows that pretreatment with 12-0-tetradecanoylphorbol 13-acetate (TPA) inhibited the effects of thrombin on both Mn2+ uptake and Ca2+ release from the intracellular stores. The responses to ADP and platelet-activating factor (PAF) were also fully prevented by TPA treatment (results not shown). In contrast, the effects of arachidonic acid were little affected or not at all. TPA addition per se did not modify the uptake of Mn2+ (results not shown).
Increased levels of cyclic AMP also inhibit platelet activation by several agonists [44, 45] . When thrombin is used as the agonist, an increase in cyclic AMP prevents stimulation of phospholipase A2 and, to a lesser degree, of phospholipase C [39] . Fig. 13 shows that a 2 min pretreatment with forskolin and isobutylmethylxanthine (IBMX), a treatment known to increase cyclic AMP [46] , largely antagonized both the thrombin-induced release of Ca2+ from the intracellular stores and the acceleration of Mn2+ uptake. Similar effects were observed when ADP or PAF was used as the agonist (results not shown). In contrast, the effects of arachidonic acid on the uptake of Mn2+ were hardly affected by pretreatment with forskolin and IBMX. Fig. 14 shows the effects of arachidonic acid in another three cell preparations: human neutrophils, rat thymocytes and Ehrlich ascites-tumour cells. An acceleration of Mn2+ uptake phenomenologically similar to that described above in platelets was found in all the cases, and this was prevented by Ni2+.
DISCUSSION
We document here the effects of arachidonic acid on Ca2+ movements in human platelets. These include Ca2+ release from intracellular stores and Ca2+ entry through the plasma membrane. Ca2+ release is accepted to be mediated by InsP3 in a large variety of systems including platelets [3, 47, 48] . We show here that, as suggested before [11] [12] [13] [14] , the Ca2+-releasing effect of arachidonic acid is mediated by a cyclo-oxygenase metabolite, since it is prevented by aspirin and can be mimicked by the prostaglandin H2/thromboxane A2 analogue U46619. A maximal effect is achieved at concentrations of about 10,UM, and larger concentrations decrease the effect. This has been attributed to the generation of lipoxygenase metabolites, which antagonize thromboxane synthesis and have general inhibitory effects [17, 49] .
Arachidonic acid had been proposed previously to induce entry of Ca2+ into platelets on the basis of the Ca2+-dependence of some of its effects, and also because the increase of [Ca2+]1 is larger in the presence of external Ca2+ than in Ca2+-free medium [11] [12] [13] [14] . In the present work the use of Mn2+ as a surrogate for Ca2+ and the simultaneous and independent measurements of the plasma membrane fluxes and the mobilization from the intracellular stores have allowed a much more detailed analysis.
Since the acceleration of Mn2+ entry by arachidonic acid required rather high concentrations of the fatty acid, it was critical to exclude non-selective permeabilization of the membrane. We have shown that arachidonic acid does not permeabilize the membrane to Ni2+, H+ or trimethylammonium ions and that Ni2+ blocks the arachidonic acid-induced uptake of Mn2+. The fact that none of the other fatty acids tested was able to increase the plasma membrane permeability to Mn2+, except at higher concentrations (Table 1) , also argues against a nonselective effect. We must conclude that the effects of arachidonic acid on the uptake of Mn2+ cannot be attributed to cell lysis or to non-specific plasma membrane permeabilization.
Activation of ion channels by lipoxygenase metabolites of arachidonic acid has been reported in several cells [37, 38] . In platelets neither the inhibitors of cyclo-oxygenase nor those of lipoxygenase prevented the effects of arachidonic acid on the uptake of Mn2+. This suggests that arachidonic acid acts as such, with no metabolic transformation, on plasma membrane permeability. The fact that other non-metabolizable polyunsaturated fatty acids, which are unable to produce release of Ca2+ from the intracellular stores, also increased the plasma membrane permeability to Mn2+ (although only at higher concentrations) reinforces the above conclusion.
The activation of the phospholipase C/PKC system is involved in many of the effects of thrombin [1] [2] [3] and arachidonic acid and other unsaturated fatty acids are able to activate PKC directly [13, 35] . Since several examples are known of channels which are regulated by phosphorylation [50] [51] [52] , the possible mediation of PKC in this case should be considered. Direct activation of PKC by TPA did not, however, increase the uptake of Mn2 . On the other hand, pretreatment with TPA, which should down-regulate PKC [3, 53, 54] , did not prevent the effect of arachidonic acid. Finally, the selectivity found here for arachidonic acid over other fatty acids for acceleration of the uptake of Mn2+ is more strict than that reported for activation of PKC [13] . All of these observations suggest that the increase in Ca2+ (Mn2+) influx induced by arachidonic acid is not mediated by PKC activation.
Since thrombin induces generation of arachidonic acid by activation of phospholipase A2 [17] , the possibility that arachidonic acid could mediate the effect of thrombin should be considered. It has been reported before that Ca2+ mobilization induced by thrombin is decreased by treatment with phospholipase A2 inhibitor ONO-RS-082 [15] . On the other hand, microinjection of phospholipase A2 increased Ca2+ influx in cultured endothelial cells [18] . The increase in cyclic AMP, which is known to block the activation of phospholipase A2 effected by thrombin [39] , prevented the acceleration of Mn2+ uptake induced by thrombin, but it did not modify the effect of added arachidonic acid (Fig. 13) . The observation that the effects of maximal concentrations of arachidonic acid and thrombin on Mn2+ uptake were not additive (Fig. 9) open the same Ca21 (Mn2+) pathway of the plasma membrane. However, the fact that low concentrations of arachidonic acid inhibited the effect of thrombin allows to reinterpret the lack of additivity as due to abolition of the effect of thrombin by high concentrations of arachidonic acid. The divalent cation selectivity of the plasma membrane pathways opened by arachidonic acid and thrombin were similar. In addition to Ca2+, the cations Ba2+, Mn2+ and Co2+, but not Ni2+, could pass through this channel. Furthermore, Ni2+ blocked the fluxes of the other divalent cations in all cases. Arachidonic acid, but not thrombin, increased the permeability to Mg2+. The Mg2+ fluxes were also blocked by Ni2+. These results indicate that the plasma membrane pathway activated by arachidonic acid is not the same as that opened by thrombin. Consequently, it is unlikely that arachidonic acid mediates the effects of thrombin on the plasma membrane permeability to Ca2 . It has been reported recently that arachidonic acid is able to release 45Ca from plasma membrane vesicles [15] and from microsomes [16] prepared from human platelets. The selectivity of arachidonic acid compared with other fatty acids was similar to that reported here. These effects were attributed to a ionophoric mechanism, although the presence of an endogenous membrane component was also required [16] . Our results are consistent with this interpretation. The results obtained in the three other cell types tested here indicate that the ionophoric effects of arachidonic acid are not restricted to platelets.
